MTL-CEBPA: Phase I started

MiNA began the open-label, U.K. Phase I OUTREACH trial to evaluate IV MTL-CEBPA

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE